CY1118348T1 - Μεθοδος παρασκευης μεταξαλονης - Google Patents
Μεθοδος παρασκευης μεταξαλονηςInfo
- Publication number
- CY1118348T1 CY1118348T1 CY20161101242T CY161101242T CY1118348T1 CY 1118348 T1 CY1118348 T1 CY 1118348T1 CY 20161101242 T CY20161101242 T CY 20161101242T CY 161101242 T CY161101242 T CY 161101242T CY 1118348 T1 CY1118348 T1 CY 1118348T1
- Authority
- CY
- Cyprus
- Prior art keywords
- solvent
- tgic
- reaction
- dielectric constant
- mixture containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Η παρούσα εφεύρεση αφορά μια μέθοδο παρασκευής της μεταξαλόνης που περιλαμβάνει αντίδραση του ισοκυανικού άλατος τριγλυκιδυλίου (TGIC) με την m-ξυλενόλη, που χαρακτηρίζεται από το ότι η εν λόγω αντίδραση εκτελείται σε ένα μείγμα διαλύτη που περιέχει ένα απρωτικό πολικό διαλύτη με διηλεκτρική σταθερά μεγαλύτερη από ή ίση με 30 και τουλάχιστον έναν άλλο διαλύτη που επιλέγεται από την ομάδα που περιλαμβάνει απολικούς διαλύτες και απρωτικούς πολικούς διαλύτες με διηλεκτρική σταθερά κάτω από το 30 με το εν λόγω μείγμα διαλύτη να περιέχει από 5 έως 40 % του βάρους του εν λόγω πρώτου διαλύτη και από 95 έως 60 % του βάρους του εν λόγω δεύτερου διαλύτη, προσθέτοντας το TGIC σε μια θερμοκρασία μεταξύ 30°C και 50°C, και στη συνέχεια προσθέτοντας το TGIC, αυξάνοντας τη θερμοκρασία του διαλύματος της αντίδρασης σε μια τιμή μεταξύ 80°C και 180°C εντός χρονικού διαστήματος μεταξύ 120 και 180 λεπτών με έναν ρυθμό αύξησης όχι μεγαλύτερο από 1,25°C ανά λεπτό. Η εφεύρεση αφορά επίσης μια μεταξαλόνη με μια μειωμένη περιεκτικότητα ακαθαρσιών που προέρχονται από τις ατελείς αντίδρασης ή/και παράπλευρες αντιδράσεις της μεθόδου παραγωγής.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11152849 | 2011-02-01 | ||
| US201161439127P | 2011-02-03 | 2011-02-03 | |
| EP12700288.9A EP2670737B1 (en) | 2011-02-01 | 2012-01-17 | Method of preparation of metaxalone |
| PCT/EP2012/050609 WO2012104139A1 (en) | 2011-02-01 | 2012-01-17 | Method of preparation of metaxalone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1118348T1 true CY1118348T1 (el) | 2017-06-28 |
Family
ID=44115617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20161101242T CY1118348T1 (el) | 2011-02-01 | 2016-12-01 | Μεθοδος παρασκευης μεταξαλονης |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US20130261160A1 (el) |
| EP (1) | EP2670737B1 (el) |
| JP (1) | JP2014503564A (el) |
| KR (1) | KR101907599B1 (el) |
| CN (1) | CN103298797B (el) |
| AR (1) | AR084946A1 (el) |
| AU (1) | AU2012213666B2 (el) |
| BR (1) | BR112013013134B1 (el) |
| CA (1) | CA2817462C (el) |
| CY (1) | CY1118348T1 (el) |
| DK (1) | DK2670737T3 (el) |
| EA (1) | EA024417B1 (el) |
| ES (1) | ES2605425T3 (el) |
| GE (1) | GEP20156352B (el) |
| HK (1) | HK1191006A1 (el) |
| HR (1) | HRP20161660T1 (el) |
| HU (1) | HUE029476T2 (el) |
| IL (1) | IL226329A (el) |
| LT (1) | LT2670737T (el) |
| MX (1) | MX339346B (el) |
| PL (1) | PL2670737T3 (el) |
| PT (1) | PT2670737T (el) |
| SG (2) | SG10201600357WA (el) |
| SI (1) | SI2670737T1 (el) |
| SM (1) | SMT201600415B (el) |
| UA (1) | UA114593C2 (el) |
| WO (1) | WO2012104139A1 (el) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102181881B1 (ko) | 2014-11-21 | 2020-11-24 | 삼성디스플레이 주식회사 | 비전 검사 장치 및 이의 감마 및 얼룩 보정 방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1487641A (fr) | 1965-07-24 | 1967-07-07 | Henkel & Cie Gmbh | Procédé de préparation d'oxazolidones substituées |
| DE1545951A1 (de) * | 1965-07-24 | 1970-05-14 | Henkel & Cie Gmbh | Verfahren zur Herstellung von substituierten Oxazolidonen |
| WO2003061552A2 (en) * | 2002-01-14 | 2003-07-31 | Sun Pharmaceutical Industries Limited | Novel process for the preparation of substantially pure 5-(3,5-dimethylphenoxy)methyl-2-oxazolidinone |
| US6562980B1 (en) * | 2002-08-19 | 2003-05-13 | Yung Shin Pharma Ind. Co., Ltd. | Method for producing 5-aryloxymethyl-2-oxazolidinones |
| WO2007074477A2 (en) * | 2005-12-29 | 2007-07-05 | Dabur Pharma Limited | Metaxalone polymorphs |
| WO2008006096A1 (en) | 2006-07-07 | 2008-01-10 | Boehringer Ingelheim Chemicals, Inc. | Metaxalone synthesis |
| CN101921241A (zh) * | 2009-06-12 | 2010-12-22 | 北京京卫燕康药物研究所有限公司 | 具有光学活性的美他沙酮的合成 |
-
2012
- 2012-01-17 PT PT127002889T patent/PT2670737T/pt unknown
- 2012-01-17 US US13/990,974 patent/US20130261160A1/en not_active Abandoned
- 2012-01-17 KR KR1020137016255A patent/KR101907599B1/ko active IP Right Grant
- 2012-01-17 JP JP2013550823A patent/JP2014503564A/ja active Pending
- 2012-01-17 UA UAA201305952A patent/UA114593C2/uk unknown
- 2012-01-17 DK DK12700288.9T patent/DK2670737T3/en active
- 2012-01-17 WO PCT/EP2012/050609 patent/WO2012104139A1/en active Application Filing
- 2012-01-17 HU HUE12700288A patent/HUE029476T2/en unknown
- 2012-01-17 CN CN201280004303.XA patent/CN103298797B/zh active Active
- 2012-01-17 ES ES12700288.9T patent/ES2605425T3/es active Active
- 2012-01-17 EA EA201390787A patent/EA024417B1/ru unknown
- 2012-01-17 AU AU2012213666A patent/AU2012213666B2/en active Active
- 2012-01-17 PL PL12700288T patent/PL2670737T3/pl unknown
- 2012-01-17 BR BR112013013134-9A patent/BR112013013134B1/pt active IP Right Grant
- 2012-01-17 GE GEAP201213202A patent/GEP20156352B/en unknown
- 2012-01-17 SI SI201230789A patent/SI2670737T1/sl unknown
- 2012-01-17 SG SG10201600357WA patent/SG10201600357WA/en unknown
- 2012-01-17 MX MX2013008426A patent/MX339346B/es active IP Right Grant
- 2012-01-17 EP EP12700288.9A patent/EP2670737B1/en active Active
- 2012-01-17 LT LTEP12700288.9T patent/LT2670737T/lt unknown
- 2012-01-17 CA CA2817462A patent/CA2817462C/en active Active
- 2012-01-17 SG SG2013055991A patent/SG192090A1/en unknown
- 2012-01-30 AR ARP120100285A patent/AR084946A1/es active IP Right Grant
-
2013
- 2013-05-13 IL IL226329A patent/IL226329A/en active IP Right Grant
-
2014
- 2014-04-30 HK HK14104176.2A patent/HK1191006A1/zh unknown
-
2015
- 2015-06-17 US US14/742,203 patent/US9416116B2/en active Active
-
2016
- 2016-11-15 SM SM201600415T patent/SMT201600415B/it unknown
- 2016-12-01 CY CY20161101242T patent/CY1118348T1/el unknown
- 2016-12-06 HR HRP20161660TT patent/HRP20161660T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2013006585A (es) | Compuestos de anillo indeno fusionados. | |
| MX2016000484A (es) | Sintesis de bis(fluorosulfonil)imida de hidrogeno. | |
| BR112015005891A2 (pt) | método de sintetizar análogos do hormônio da tireoide e polimorfos destes | |
| JP2015532645A5 (el) | ||
| NI201100211A (es) | Método mejorado para sintetizar pirfenidona | |
| MX2016007952A (es) | Mono- y dialquil-eteres de furan-2,5-dimetanol y (tetra-hidrofuran-2,5-diil)dimetanol y derivados anfifilos de los mismos. | |
| PH12019502093A1 (en) | Novel ester compounds, method for the production thereof and use thereof | |
| CY1121484T1 (el) | Μορφες αλατος και κρυσταλλου ενος αναστολεα plk-4 | |
| CL2013002436A1 (es) | Proceso para preparar una forma cristalina anhidra de ((s)-1-hidroximetil-2,2-dimetilpropil)amida del acido ( 1as,5as)-2-(4-oxipirazin-2-il)-1a,2,5,5a-tetrahidro-1h-2,3-diazaciclopropa[a]pentaleno-4-carboxilico; forma cristalina; composicion farmaceutica; proceso para prepararla; solvato; y uso para tratar dolor y osteoporosis. | |
| EA202191502A1 (ru) | Способ получения апиксабана | |
| CL2020001049A1 (es) | Proceso para producir compuestos de piridazinona herbicida. | |
| MX2023000045A (es) | Nuevos procesos e intermediarios para la preparacion de estimulantes de guanilato ciclasa soluble. | |
| EA201891808A1 (ru) | Трис-амидные соединения и композиции, содержащие их | |
| EA202192581A1 (ru) | Композиции d-метирозина и способы их получения | |
| CY1118348T1 (el) | Μεθοδος παρασκευης μεταξαλονης | |
| EP4249488A3 (en) | Novel processes for preparation of soluble guanylate cyclase stimulators | |
| EA201791533A1 (ru) | Способ производства лактида | |
| MX2019000138A (es) | Procesos novedosos para preparacion de estimuladores de guanilato ciclasa soluble. | |
| MY196769A (en) | Synthesis of a thiosulfonic acid by a step of periodate mediated oxidative coupling of a thiosulfonic acid with an aniline | |
| PH12016500749B1 (en) | A method for preparing an intermediate of iopromide | |
| RU2014118603A (ru) | Жидкие смеси стабилизаторов | |
| MX2021000226A (es) | Nuevo proceso para la preparacion de diamidas antranilicas. | |
| DOP2013000035A (es) | Procedimiento para preparar formas enantioméricas de derivados de ácido 2,3-diaminopropiónico | |
| CY1122959T1 (el) | Συν-κρυσταλλοι αγομελατινης και π-τολουολοσουλφονικου οξεος, μεθοδος για την παρασκευη αυτων και οι φαρμακευτικες συνθεσεις αυτων | |
| UA123716U (uk) | Обетіхолева кислота |